Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiviral drug
|
| gptkbp:CASNumber |
1191237-69-0
|
| gptkbp:chemicalFormula |
C12H13N5O4
|
| gptkbp:developedBy |
gptkb:Gilead_Sciences
|
| gptkbp:has_antiviral_activity_against |
gptkb:COVID-19
gptkb:feline_infectious_peritonitis_virus coronaviruses |
| https://www.w3.org/2000/01/rdf-schema#label |
GS-441524
|
| gptkbp:IUPACName |
gptkb:2-ethyl-1,9-dihydro-6H-purin-6-one_riboside
|
| gptkbp:legalStatus |
not approved for human use
|
| gptkbp:mechanismOfAction |
RNA-dependent RNA polymerase inhibitor
|
| gptkbp:metabolism |
gptkb:remdesivir
|
| gptkbp:molecularWeight |
291.26 g/mol
|
| gptkbp:PubChem_CID |
44468216
|
| gptkbp:relatedTo |
gptkb:remdesivir
|
| gptkbp:routeOfAdministration |
oral
subcutaneous intravenous |
| gptkbp:UNII |
6Q1K1Y1V8Q
|
| gptkbp:used_in_veterinary_medicine |
yes
|
| gptkbp:usedFor |
gptkb:feline_infectious_peritonitis
|
| gptkbp:bfsParent |
gptkb:remdesivir
|
| gptkbp:bfsLayer |
5
|